# China NMPA Drug Inspection - Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. - Aminophylline tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-shantou-jinshi-pharmaceutical-co-ltd/17be5efb-9a6a-4ba8-9fc2-fd07085d2b7b
Source feed: China

> China NMPA drug inspection for Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Aminophylline tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Aminophylline tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-shantou-jinshi-pharmaceutical-co-ltd/f74c1945-c1a6-457a-b75b-b5171a85bb0b